Dimer-plus-chain structure for the SI(100)-c(4 x 2) surface.

Northrup

DOI: https://doi.org/10.1103/PHYSREVLETT.54.815

IF: 8.6

1985-02-25

Physical Review Letters

Abstract:Proposition d'une nouvelle structure c(4×2) pour la surface Si(100) dans laquelle les atomes de la seconde couche sont dimerises et les atomes de la couche superieure forment des chaines a liaison π

What problem does this paper attempt to address?

Metabolomics Diagnosis of COVID-19 from Exhaled Breath Condensate

Elettra Barberis,Elia Amede,Shahzaib Khoso,Luigi Castello,Pier Paolo Sainaghi,Mattia Bellan,Piero Emilio Balbo,Giuseppe Patti,Diego Brustia,Mara Giordano,Roberta Rolla,Annalisa Chiocchetti,Giorgia Romani,Marcello Manfredi,Rosanna Vaschetto

DOI: https://doi.org/10.3390/metabo11120847

IF: 4.1

2021-12-06

Metabolites

Abstract:Infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to severe respiratory tract damage and acute lung injury. Therefore, it is crucial to study breath-associated biofluids not only to investigate the breath’s biochemical changes caused by SARS-CoV-2 infection, but also to discover potential biomarkers for the development of new diagnostic tools. In the present study, we performed an untargeted metabolomics approach using a bidimensional gas chromatography mass spectrometer (GCxGC-TOFMS) on exhaled breath condensate (EBC) from COVID-19 patients and negative healthy subjects to identify new potential biomarkers for the noninvasive diagnosis and monitoring of the COVID-19 disease. The EBC analysis was further performed in patients with acute or acute-on-chronic cardiopulmonary edema (CPE) to assess the reliability of the identified biomarkers. Our findings demonstrated that an abundance of EBC fatty acids can be used to discriminate COVID-19 patients and that they may have a protective effect, thus suggesting their potential use as a preventive strategy against the infection.

biochemistry & molecular biology
B-152 Analysis of carbonyl compounds in exhaled breath for detection of COVID-19

X Fu,Z Xie,J D Morris,A D Alksas,A D El-Baz,J D Huang,M H Nantz

DOI: https://doi.org/10.1093/clinchem/hvae106.512

IF: 12.114

2024-10-27

Clinical Chemistry

Abstract:BackgroundCOVID-19 pandemic has caused enormous loss of lives and economic disruption. The global crisis has resulted in more than 700 million infections and 7 million deaths worldwide. Rapid screening and detection of highly infectious respiratory diseases is a key for preventing and curbing future epidemic and pandemic. The objective of this work is to develop a novel breath analysis technique for detection of COVID-19 using chemoselective capture of carbonyl compounds in exhaled breath for analysis by gas chromatography-mass spectrometry (GC-MS). Respiratory viral infection causes oxidative stress and inflammation in its host body which leads to production of higher levels of some carbonyl compounds through oxidation of lipids and could be detected in exhaled breath. This breath analysis technique can be rapidly adapted for screening infectious respiratory diseases for future epidemic and potential pandemic.MethodsA total of 237 subjects were enrolled in this study. Of these, 142 were COVID-19 positive and 95 were negative. One liter exhaled breath in Tedlar bags from both COVID-19 positive and negative subjects confirmed by reverse transcriptase polymerase chain reaction between April 2022 and September 2023. The collected one liter breath samples were completely evacuated through a cartridge packed with silica particles in 2-3 minutes. Silica particles were coated with a reactive aminooxy agent for capture of carbonyl compounds in the breath samples through oximation reactions. The captured carbonyl compounds were eluted by methanol and the eluted solutions were analyzed by GC-MS for calculation of each compound concentration in the exhaled breath samples. Biostatistics was used to identify significant carbonyl compounds (defined as p value < 0.05) as markers of CPOVID-19 infection. A machine learning algorithm was implemented with the captured carbonyl compounds as input features for differentiation of COVID-19 positive from negative subjects.ResultsA total of more than 30 carbonyl compounds were detected in exhaled breath samples of all subjects. 10 features including 3 individual carbonyl compounds and 7 compound ratios show significant differences (p value <0.05) between COVID-19 positive and negative groups. The developed machine learning and artificial intelligence (AI) algorithms successfully separated COVOD-19 positive from negative with an accuracy of 95.4%, sensitivity of 96.5%, specificity of 93.7%, and AUROC=0.974.ConclusionsThe analysis of carbonyl compounds in exhaled breath by GC-MS has great potential for non-invasive detection of COVID-19. The method could be rapidly adapted for detection of other respiratory infectious diseases with a small sample size and data set for training of the machine learning and AI algorithms.

medical laboratory technology
Proteome profiling of home-sampled dried blood spots reveals proteins of SARS-CoV-2 infections

Claudia Fredolini,Tea Dodig-Crnković,Annika Bendes,Leo Dahl,Matilda Dale,Vincent Albrecht,Cecilia Mattsson,Cecilia E Thomas,Åsa Torinsson Naluai,Magnus Gisslen,Olof Beck,Niclas Roxhed,Jochen M Schwenk

DOI: https://doi.org/10.1038/s43856-024-00480-4

2024-04-02

Abstract:Background: Self-sampling of dried blood spots (DBS) offers new routes to gather valuable health-related information from the general population. Yet, the utility of using deep proteome profiling from home-sampled DBS to obtain clinically relevant insights about SARS-CoV-2 infections remains largely unexplored. Methods: Our study involved 228 individuals from the general Swedish population who used a volumetric DBS sampling device and completed questionnaires at home during spring 2020 and summer 2021. Using multi-analyte COVID-19 serology, we stratified the donors by their response phenotypes, divided them into three study sets, and analyzed 276 proteins by proximity extension assays (PEA). After normalizing the data to account for variances in layman-collected samples, we investigated the association of DBS proteomes with serology and self-reported information. Results: Our three studies display highly consistent variance of protein levels and share associations of proteins with sex (e.g., MMP3) and age (e.g., GDF-15). Studying seropositive (IgG+) and seronegative (IgG-) donors from the first pandemic wave reveals a network of proteins reflecting immunity, inflammation, coagulation, and stress response. A comparison of the early-infection phase (IgM+IgG-) with the post-infection phase (IgM-IgG+) indicates several proteins from the respiratory system. In DBS from the later pandemic wave, we find that levels of a virus receptor on B-cells differ between seropositive (IgG+) and seronegative (IgG-) donors. Conclusions: Proteome analysis of volumetric self-sampled DBS facilitates precise analysis of clinically relevant proteins, including those secreted into the circulation or found on blood cells, augmenting previous COVID-19 reports with clinical blood collections. Our population surveys support the usefulness of DBS, underscoring the role of timing the sample collection to complement clinical and precision health monitoring initiatives.
Detection of COVID-19 by quantitative analysis of carbonyl compounds in exhaled breath

Zhenzhen Xie,James D. Morris,Jianmin Pan,Elizabeth A. Cooke,Saurin R. Sutaria,Dawn Balcom,Subathra Marimuthu,Leslie W. Parrish,Holly Aliesky,Justin J. Huang,Shesh N. Rai,Forest W. Arnold,Jiapeng Huang,Michael H. Nantz,Xiao-An Fu

DOI: https://doi.org/10.1038/s41598-024-61735-7

IF: 4.6

2024-06-26

Scientific Reports

Abstract:COVID-19 has caused a worldwide pandemic, creating an urgent need for early detection methods. Breath analysis has shown great potential as a non-invasive and rapid means for COVID-19 detection. The objective of this study is to detect patients infected with SARS-CoV-2 and even the possibility to screen between different SARS-CoV-2 variants by analysis of carbonyl compounds in breath. Carbonyl compounds in exhaled breath are metabolites related to inflammation and oxidative stress induced by diseases. This study included a cohort of COVID-19 positive and negative subjects confirmed by reverse transcription polymerase chain reaction between March and December 2021. Carbonyl compounds in exhaled breath were captured using a microfabricated silicon microreactor and analyzed by ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS). A total of 321 subjects were enrolled in this study. Of these, 141 (85 males, 60.3%) (mean ± SD age: 52 ± 15 years) were COVID-19 (55 during the alpha wave and 86 during the delta wave) positive and 180 (90 males, 50%) (mean ± SD age: 45 ± 15 years) were negative. Panels of a total of 34 ketones and aldehydes in all breath samples were identified for detection of COVID-19 positive patients. Logistic regression models indicated high accuracy/sensitivity/specificity for alpha wave (98.4%/96.4%/100%), for delta wave (88.3%/93.0%/84.6%) and for all COVID-19 positive patients (94.7%/90.1%/98.3%). The results indicate that COVID-19 positive patients can be detected by analysis of carbonyl compounds in exhaled breath. The technology for analysis of carbonyl compounds in exhaled breath has great potential for rapid screening and detection of COVID-19 and for other infectious respiratory diseases in future pandemics.

multidisciplinary sciences
Exhaled breath condensate as bioanalyte: from collection considerations to biomarker sensing

Sabine Szunerits,Hannes Dӧrfler,Quentin Pagneux,John Daniel,Shekhar Wadekar,Eloise Woitrain,Dennis Ladage,David Montaigne,Rabah Boukherroub

DOI: https://doi.org/10.1007/s00216-022-04433-5

2022-11-18

Analytical and Bioanalytical Chemistry

Abstract:Since the SARS-CoV-2 pandemic, the potential of exhaled breath (EB) to provide valuable information and insight into the health status of a person has been revisited. Mass spectrometry (MS) has gained increasing attention as a powerful analytical tool for clinical diagnostics of exhaled breath aerosols (EBA) and exhaled breath condensates (EBC) due to its high sensitivity and specificity. Although MS will continue to play an important role in biomarker discovery in EB, its use in clinical setting is rather limited. EB analysis is moving toward online sampling with portable, room temperature operable, and inexpensive point-of-care devices capable of real-time measurements. This transition is happening due to the availability of highly performing biosensors and the use of wearable EB collection tools, mostly in the form of face masks. This feature article will outline the last developments in the field, notably the novel ways of EBA and EBC collection and the analytical aspects of the collected samples. The inherit non-invasive character of the sample collection approach might open new doors for efficient ways for a fast, non-invasive, and better diagnosis.

chemistry, analytical,biochemical research methods
Potential Use of Exhaled Breath Condensate for Diagnosis of SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis

Matteo Riccò,Alessandro Zaniboni,Elia Satta,Silvia Ranzieri,Federico Marchesi

DOI: https://doi.org/10.3390/diagnostics12092245

IF: 3.6

2022-09-18

Diagnostics

Abstract:Background. Reverse-transcriptase polymerase chain reaction (RT-qPCR) assays performed on respiratory samples collected through nasal swabs still represent the gold standard for COVID-19 diagnosis. Alternative methods to this invasive and time-consuming options are still being inquired, including the collection of airways lining fluids through exhaled breath condensate (EBC). Materials and Methods. We performed a systematic review and meta-analysis in order to explore the reliability of EBC as a way to collect respiratory specimens for RT-qPCR for diagnosis of COVID-19. Results. A total of 4 studies (205 specimens), were ultimately collected, with a pooled sensitivity of 69.5% (95%CI 26.8–93.4), and a pooled specificity of 98.3% (95%CI 87.8–99.8), associated with high heterogeneity and scarce diagnostic agreement with the gold standard represented by nasal swabs (Cohen's kappa = 0.585). Discussion. Even though non-invasive options for diagnosis of COVID-19 are still necessary, EBC-based RT-qPCR showed scarce diagnostic performances, ultimately impairing its implementation in real-world settings. However, as few studies have been carried out to date, and the studies included in the present review are characterized by low numbers and low sample power, further research are requested to fully characterize the actual reliability of EBC-based RT-qPCR in the diagnosis of COVID-19.

medicine, general & internal
Review of non-invasive detection of SARS-CoV-2 and other respiratory pathogens in exhaled breath condensate

Emeka Nwanochie,Jacqueline C Linnes

DOI: https://doi.org/10.1088/1752-7163/ac59c7

2022-03-18

Journal of Breath Research

Abstract:Abstract In 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged to cause high viral infectivity and severe respiratory illness in humans (COVID-19). Worldwide, limited pandemic mitigation strategies, including lack of diagnostic test availability, resulted in COVID-19 overrunning health systems and spreading throughout the global population. Currently, proximal respiratory tract (PRT) specimens such as nasopharyngeal swabs are used to diagnose COVID-19 because of their relative ease of collection and applicability in large scale screening. However, localization of SARS-CoV-2 in the distal respiratory tract (DRT) is associated with more severe infection and symptoms. Exhaled breath condensate (EBC) is a sample matrix comprising aerosolized droplets originating from alveolar lining fluid that are further diluted in the DRT and then PRT and collected via condensation during tidal breathing. The COVID-19 pandemic has resulted in recent resurgence of interest in EBC collection as an alternative, non-invasive sampling method for the staging and accurate detection of SARS-CoV-2 infections. Herein, we review the potential utility of EBC collection for detection of SARS-CoV-2 and other respiratory infections. While much remains to be discovered in fundamental EBC physiology, pathogen-airway interactions, and optimal sampling protocols, EBC, combined with emerging detection methods, presents a promising non-invasive sample matrix for detection of SARS-CoV-2.

biochemical research methods,respiratory system
Machine learning enabled detection of COVID-19 pneumonia using exhaled breath analysis: a proof-of-concept study.

Ruth P Cusack,Robyn Larracy,Christian B Morrell,Maral Ranjbar,Jennifer Le Roux,Christiane E Whetstone,Maxime Boudreau,Patrick F Poitras,Thivya Srinathan,Eric Cheng,Karen Howie,Catie Obminski,Tim O'Shea,Rebecca Kruisselbrink,Terence Ho,Erik Scheme,Stephen Graham,Gisia Beydaghyan,Gail M Gauvreau,Mylinh Duong

DOI: https://doi.org/10.1088/1752-7163/ad2b6e

2024-02-22

Journal of Breath Research

Abstract:Background Detection of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) relies on real-time-reverse-transcriptase polymerase chain reaction (RT-PCR) on nasopharyngeal swabs. The false-negative rate of RT-PCR can be high when viral burden and infection is localized distally in the lower airways and lung parenchyma. An alternate safe, simple and accessible method for sampling the lower airways is needed to aid in the early and rapid diagnosis of COVID-19 pneumonia. Methods In a prospective unblinded observational study, patients admitted with a positive RT-PCR and symptoms of SARS-CoV-2 infection were enrolled from three hospitals in Ontario, Canada. Healthy individuals or hospitalized patients with negative RT-PCR and without respiratory symptoms were enrolled into the control group. Breath samples were collected and analyzed by laser absorption spectroscopy (LAS) for volatile organic compounds (VOC) and classified by machine learning (ML) approaches to identify unique LAS-spectra patterns (breathprints) for SARS-CoV-2. Findings Of the 135 patients enrolled, 115 patients provided analyzable breath samples. Using LAS-breathprints to train ML classifier models resulted in an accuracy of 72·2-81·7% in differentiating between SARS-CoV2 positive and negative groups. The performance was consistent across subgroups of different age, sex, BMI, SARS-CoV-2 variants, time of disease onset and oxygen requirement. The overall performance was higher than compared to VOC-trained classifier model, which had an accuracy of 63-74·7%. Conclusion This study demonstrates that a ML-based breathprint model using LAS analysis of exhaled breath may be a valuable non-invasive method for studying the lower airways and detecting SARS-CoV-2 and other respiratory pathogens. The technology and the ML approach can be easily deployed in any settting with minimal training. This will greatly improve access and scalability to meet surge capacity; allow early and rapid detection to inform therapy; and offers great versatility in developing new classifier models quickly for future outbreaks.

biochemical research methods,respiratory system
RT-PCR diagnosis of COVID-19 from exhaled breath condensate: a clinical study

Makoto Sawano,Kyousuke Takeshita,Hideaki Ohno,Hideaki Oka

DOI: https://doi.org/10.1088/1752-7163/ac0414

2021-06-10

Journal of Breath Research

Abstract:Abstract Current diagnostic testing for coronavirus disease 2019 (COVID-19) is based on detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasopharyngeal swab samples by reverse transcription polymerase chain reaction (RT-PCR). However, this test is associated with increased risks of viral dissemination and environmental contamination and shows relatively low sensitivity, attributable to technical deficiencies in the sampling method. Given that COVID-19 is transmitted via exhaled aerosols and droplets, and that exhaled breath condensate (EBC) is an established modality for sampling exhaled aerosols, detection of SARS-CoV-2 in EBC offers a promising diagnostic approach. However, current knowledge on the detection and load of the virus in EBC collected from COVID-19 patients remains limited and inconsistent. The objective of the study was to quantify the viral load in EBC collected from COVID-19 patients and to validate the feasibility of SARS-CoV-2 detection from EBC as a diagnostic test for the infection. EBC samples were collected from 48 COVID-19 patients using a collection device, and viral loads were quantified by RT-PCR targeting the E gene. Changes in detection rates and viral loads relative to patient characteristics and days since disease onset were statistically evaluated. Need for mechanical ventilation was significantly associated with higher viral load ( p < 0.05). Need for oxygen administration or mechanical ventilation, less than 3 d since onset, and presence of cough or fever were significantly associated with higher detection rates ( p < 0.05). Among spontaneously breathing patients, viral load in EBC attenuated exponentially over time. The detection rate was 86% at 2 d since onset and deteriorated thereafter. In mechanically ventilated patients, detection rate and viral load were high regardless of days since onset. These results support the feasibility of using RT-PCR to detect SARS-CoV-2 from EBC for COVID-19 patients within 2 d of symptom onset.

biochemical research methods,respiratory system
Head injury secondary to ruptured abdominal aortic aneurysm: an unusual presentation.

J. Paraskevopoulos,D. Teasdale,R. Cuschieri

DOI: https://doi.org/10.1016/0020-1383(95)90014-O

IF: 2.687

1995-05-01

Injury

Abstract:
The Implication of Biomarkers in Exhaled Breath Condensate of Chronic Obstructive Pulmonary Disease

Dong Xiaoqi,Zhou Jianya,Zhou Jianying

DOI: https://doi.org/10.3760/cma.j.issn.1673-436x.2017.01.012

2017-01-01

Abstract:Chronic obstructive pulmonary disease(COPD) is one of the common diseases with high morbidity and mortality rates around the world,while the pathogenesis remains elusive.COPD is mainly related to the chronic inflammation of the airway,lung parenchyma and pulmonary vessels,oxidative stress and the imbalance of protease and anti-protease.Exhaled breath condensate (EBC) can effectively collect the aerosols and volatile molecules formed in airway surface,which is an important source of specimens that can reflect the changes in the internal environment of airway leads by oxidative damage,inflammation and treatment.The EBC analysis is also a noninvasive,simple method for monitoring the inflammatory process in the development and the acute exacerbation of COPD.
A mask-based diagnostic platform for point-of-care screening of Covid-19

John Daniels,Shekhar Wadekar,Ken DeCubellis,George W. Jackson,Alexander S. Chiu,Quentin Pagneux,Hiba Saada,Ilka Engelmann,Judith Ogiez,Delphine Loze-Warot,Rabah Boukherroub,Sabine Szunerits

DOI: https://doi.org/10.1016/j.bios.2021.113486

IF: 12.545

2021-11-01

Biosensors and Bioelectronics

Abstract:<p>Diagnostics of SARS-CoV-2 infection using real-time reverse-transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs is now well-established, with saliva-based testing being lately more widely implemented for being more adapted for self-testing approaches. In this study, we introduce a different concept based on exhaled breath condensates (EBC), readily collected by a mask-based sampling device, and detection with an electrochemical biosensor with a modular architecture that enables fast and specific detection and quantification of COVID-19. The face mask forms an exhaled breath vapor containment volume to hold the exhaled breath vapor in proximity to the EBC collector to enable a condensate-forming surface, cooled by a thermal mass, to coalesce the exhaled breath into 200-500 μL fluid sample in 2 minutes. EBC RT-PCR for SARS-CoV-2 genes (E, ORF1ab) on samples collected from 7 SARS-CoV-2 positive and 7 SARS-CoV-2 negative patients were performed. The presence of SARS-CoV-2 could be detected in 5 out of 7 SARS-CoV-2 positive patients. Furthermore, the EBS samples were screened on an electrochemical aptamer biosensor, which detects SARS-CoV-2 viral particles down to 10 pfu mL<sup>-1</sup> in cultured SARS-CoV-2 suspensions. Using a "turn off" assay via ferrocenemethanol of redox mediator, results about the infectivity state of the patience are obtained in 10 min.</p>

biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology
Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19)

Daniel J Ryan,Sinead Toomey,Stephen F Madden,Michelle Casey,Oscar S Breathnach,Patrick G Morris,Liam Grogan,Peter Branagan,Richard W Costello,Eoghan De Barra,Killian Hurley,Cedric Gunaratnam,Noel G McElvaney,Michael Emmet OBrien,Imran Sulaiman,Ross K Morgan,Bryan T Hennessy

DOI: https://doi.org/10.1136/thoraxjnl-2020-215705

2020-10-23

Thorax

Abstract:False negatives from nasopharyngeal swabs (NPS) using reverse transcriptase PCR (RT-PCR) in SARS-CoV-2 are high. Exhaled breath condensate (EBC) contains lower respiratory droplets that may improve detection. We performed EBC RT-PCR for SARS-CoV-2 genes (E, S, N, ORF1ab) on NPS-positive (n=16) and NPS-negative/clinically positive COVID-19 patients (n=15) using two commercial assays. EBC detected SARS-CoV-2 in 93.5% (29/31) using the four genes. Pre-SARS-CoV-2 era controls (n=14) were negative. EBC was positive in NPS negative/clinically positive patients in 66.6% (10/15) using the identical E and S (E/S) gene assay used for NPS, 73.3% (11/15) using the N/ORF1ab assay and 14/15 (93.3%) combined.

respiratory system
COVID-19 Detection from Exhaled Breath

Nicolo Bellarmino,Giorgio Bozzini,Riccardo Cantoro,Francesco Castelletti,Michele Castelluzzo,Carla Ciricugno,Raffaele Correale,Daniela Dalla Gasperina,Francesco Dentali,Giovanni Poggialini,Piergiorgio Salerno,Giovanni Squillero,Stefano Taborelli

2024-04-25

Abstract:The SARS-CoV-2 coronavirus emerged in 2019, causing a COVID-19 pandemic that resulted in 7 million deaths out of 770 million reported cases over the next four years. The global health emergency called for unprecedented efforts to monitor and reduce the rate of infection, pushing the study of new diagnostic methods. In this paper, we introduce a cheap, fast, and non-invasive detection system, which exploits only the exhaled breath. Specifically, provided an air sample, the mass spectra in the 10--351 mass-to-charge range are measured using an original nano-sampling device coupled with a high-precision spectrometer; then, the raw spectra are processed by custom software algorithms; the clean and augmented data are eventually classified using state-of-the-art machine-learning algorithms. An uncontrolled clinical trial was conducted between 2021 and 2022 on some 300 subjects who were concerned about being infected, either due to exhibiting symptoms or having quite recently recovered from illness. Despite the simplicity of use, our system showed a performance comparable to the traditional polymerase-chain-reaction and antigen testing in identifying cases of COVID-19 (that is, 0.95 accuracy, 0.94 recall, 0.96 specificity, and 0.92 F1-score). In light of these outcomes, we think that the proposed system holds the potential for substantial contributions to routine screenings and expedited responses during future epidemics, as it yields results comparable to state-of-the-art methods, providing them in a more rapid and less invasive manner.

Machine Learning,Quantitative Methods
Effects of Contagious Respiratory Pathogens on Breath Biomarkers

Nele Kemnitz,Patricia Fuchs,Rasmus Remy,Leo Ruehrmund,Julia Bartels,Ann-Christin Klemenz,Phillip Trefz,Wolfram Miekisch,Jochen K. Schubert,Pritam Sukul

DOI: https://doi.org/10.3390/antiox13020172

IF: 7.675

2024-01-29

Antioxidants

Abstract:Due to their immediate exhalation after generation at the cellular/microbiome levels, exhaled volatile organic compounds (VOCs) may provide real-time information on pathophysiological mechanisms and the host response to infection. In recent years, the metabolic profiling of the most frequent respiratory infections has gained interest as it holds potential for the early, non-invasive detection of pathogens and the monitoring of disease progression and the response to therapy. Using previously unpublished data, randomly selected individuals from a COVID-19 test center were included in the study. Based on multiplex PCR results (non-SARS-CoV-2 respiratory pathogens), the breath profiles of 479 subjects with the presence or absence of flu-like symptoms were obtained using proton-transfer-reaction time-of-flight mass spectrometry. Among 223 individuals, one respiratory pathogen was detected in 171 cases, and more than one pathogen in 52 cases. A total of 256 subjects had negative PCR test results and had no symptoms. The exhaled VOC profiles were affected by the presence of Haemophilus influenzae, Streptococcus pneumoniae, and Rhinovirus. The endogenous ketone, short-chain fatty acid, organosulfur, aldehyde, and terpene concentrations changed, but only a few compounds exhibited concentration changes above inter-individual physiological variations. Based on the VOC origins, the observed concentration changes may be attributed to oxidative stress and antioxidative defense, energy metabolism, systemic microbial immune homeostasis, and inflammation. In contrast to previous studies with pre-selected patient groups, the results of this study demonstrate the broad inter-individual variations in VOC profiles in real-life screening conditions. As no unique infection markers exist, only concentration changes clearly above the mentioned variations can be regarded as indicative of infection or colonization.

biochemistry & molecular biology,chemistry, medicinal,food science & technology
Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study

Stanislas Grassin-Delyle,Camille Roquencourt,Pierre Moine,Gabriel Saffroy,Stanislas Carn,Nicholas Heming,Jérôme Fleuriet,Hélène Salvator,Emmanuel Naline,Louis-Jean Couderc,Philippe Devillier,Etienne A. Thévenot,Djillali Annane,for the Garches COVID-19 Collaborative GroupRECORDS Collaborators and Exhalomics® Collaborators

DOI: https://doi.org/10.1016/j.ebiom.2020.103154

IF: 11.205

2021-01-01

EBioMedicine

Abstract:BackgroundEarly diagnosis of coronavirus disease 2019 (COVID-19) is of the utmost importance but remains challenging. The objective of the current study was to characterize exhaled breath from mechanically ventilated adults with COVID-19.MethodsIn this prospective observational study, we used real-time, online, proton transfer reaction time-of-flight mass spectrometry to perform a metabolomic analysis of expired air from adults undergoing invasive mechanical ventilation in the intensive care unit due to severe COVID-19 or non-COVID-19 acute respiratory distress syndrome (ARDS).FindingsBetween March 25th and June 25th, 2020, we included 40 patients with ARDS, of whom 28 had proven COVID-19. In a multivariate analysis, we identified a characteristic breathprint for COVID-19. We could differentiate between COVID-19 and non-COVID-19 ARDS with accuracy of 93% (sensitivity: 90%, specificity: 94%, area under the receiver operating characteristic curve: 0•94-0•98, after cross-validation). The four most prominent volatile compounds in COVID-19 patients were methylpent-2-enal, 2,4-octadiene 1-chloroheptane, and nonanal.InterpretationThe real-time, non-invasive detection of methylpent-2-enal, 2,4-octadiene 1-chloroheptane, and nonanal in exhaled breath may identify ARDS patients with COVID-19.FundingThe study was funded by Agence Nationale de la Recherche (SoftwAiR, ANR-18-CE45-0017 and RHU4 RECORDS, Programme d'Investissements d'Avenir, ANR-18-RHUS-0004), Région Île de France (SESAME 2016), and Fondation Foch.

medicine, research & experimental
Oxylipin concentration shift in exhaled breath condensate (EBC) of SARS-CoV-2 infected patients

Eva Borras,Mitchell M McCartney,Dante E Rojas,Tristan L Hicks,Nam K Tran,Tina Tham,Maya M Juarez,Lisa Franzi,Richart W Harper,Cristina E Davis,Nicholas J Kenyon

DOI: https://doi.org/10.1088/1752-7163/acea3d

2023-08-07

Abstract:Infection of airway epithelial cells with severe acute respiratory coronavirus 2 (SARS-CoV-2) can lead to severe respiratory tract damage and lung injury with hypoxia. It is challenging to sample the lower airways non-invasively and the capability to identify a highly representative specimen that can be collected in a non-invasive way would provide opportunities to investigate metabolomic consequences of COVID-19 disease. In the present study, we performed a targeted metabolomic approach using liquid chromatography coupled with high resolution chromatography (LC-MS) on exhaled breath condensate (EBC) collected from hospitalized COVID-19 patients (COVID+) and negative controls, both non-hospitalized and hospitalized for other reasons (COVID-). We were able to noninvasively identify and quantify inflammatory oxylipin shifts and dysregulation that may ultimately be used to monitor COVID-19 disease progression or severity and response to therapy. We also expected EBC-based biochemical oxylipin changes associated with COVID-19 host response to infection. The results indicated ten targeted oxylipins showing significative differences between SAR-CoV-2 infected EBC samples and negative control subjects. These compounds were prostaglandins A2 and D2, LXA4, 5-HETE, 12-HETE, 15-HETE, 5-HEPE, 9-HODE, 13-oxoODE and 19(20)-EpDPA, which are associated with specific pathways (i.e. P450, COX, 15-LOX) related to inflammatory and oxidative stress processes. Moreover, all these compounds were up-regulated by COVID+, meaning their concentrations were higher in subjects with SAR-CoV-2 infection. Given that many COVID-19 symptoms are inflammatory in nature, this is interesting insight into the pathophysiology of the disease. Breath monitoring of these and other EBC metabolites presents an interesting opportunity to monitor key indicators of disease progression and severity.
Integrative proteomic profiling of lung tissues and blood in acute respiratory distress syndrome

Rui Gong,Hong Luo,Gangyu Long,Jiqian Xu,Chaolin Huang,Xin Zhou,You Shang,Dingyu Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1158951

IF: 7.3

2023-05-02

Frontiers in Immunology

Abstract:Introduction: Acute respiratory distress syndrome and acute lung injury (ARDS/ALI) still lack a recognized diagnostic test and pharmacologic treatments that target the underlying pathology. Methods: To explore the sensitive non-invasive biomarkers associated with pathological changes in the lung of direct ARDS/ALI, we performed an integrative proteomic analysis of lung and blood samples from lipopolysaccharide (LPS)-induced ARDS mice and COVID-19-related ARDS patients. The common differentially expressed proteins (DEPs) were identified based on combined proteomic analysis of serum and lung samples in direct ARDS mice model. The clinical value of the common DEPs was validated in lung and plasma proteomics in cases of COVID-19-related ARDS. Results: We identified 368 DEPs in serum and 504 in lung samples from LPS-induced ARDS mice. Gene ontology (GO) classification and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that these DEPs in lung tissues were primarily enriched in pathways, including IL-17 and B cell receptor signaling pathways, and the response to stimuli. In contrast, DEPs in the serum were mostly involved in metabolic pathways and cellular processes. Through network analysis of protein-protein interactions (PPI), we identified diverse clusters of DEPs in the lung and serum samples. We further identified 50 commonly upregulated and 10 commonly downregulated DEPs in the lung and serum samples. Internal validation with a parallel-reacted monitor (PRM) and external validation in the Gene Expression Omnibus (GEO) datasets further showed these confirmed DEPs. We then validated these proteins in the proteomics of patients with ARDS and identified six proteins (HP, LTA4H, S100A9, SAA1, SAA2, and SERPINA3) with good clinical diagnostic and prognostic value. Discussion: These proteins can be viewed as sensitive and non-invasive biomarkers associated with lung pathological changes in the blood and could potentially serve as targets for the early detection and treatment of direct ARDS especially in hyperinflammatory subphenotype.

immunology
MD Spiral CT appearances of pancreatic tail insulinoma

A. Hilendarov,A. Nedeva,A. Petrova,E. Simova

2014-09-01

Abstract:

Dimer-plus-chain structure for the SI(100)-c(4 x 2) surface.

Metabolomics Diagnosis of COVID-19 from Exhaled Breath Condensate

B-152 Analysis of carbonyl compounds in exhaled breath for detection of COVID-19

Proteome profiling of home-sampled dried blood spots reveals proteins of SARS-CoV-2 infections

Detection of COVID-19 by quantitative analysis of carbonyl compounds in exhaled breath

Exhaled breath condensate as bioanalyte: from collection considerations to biomarker sensing

Potential Use of Exhaled Breath Condensate for Diagnosis of SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis

Review of non-invasive detection of SARS-CoV-2 and other respiratory pathogens in exhaled breath condensate

Machine learning enabled detection of COVID-19 pneumonia using exhaled breath analysis: a proof-of-concept study.

RT-PCR diagnosis of COVID-19 from exhaled breath condensate: a clinical study

Head injury secondary to ruptured abdominal aortic aneurysm: an unusual presentation.

The Implication of Biomarkers in Exhaled Breath Condensate of Chronic Obstructive Pulmonary Disease

A mask-based diagnostic platform for point-of-care screening of Covid-19

Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19)

COVID-19 Detection from Exhaled Breath

Effects of Contagious Respiratory Pathogens on Breath Biomarkers

Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study

Oxylipin concentration shift in exhaled breath condensate (EBC) of SARS-CoV-2 infected patients

Integrative proteomic profiling of lung tissues and blood in acute respiratory distress syndrome

MD Spiral CT appearances of pancreatic tail insulinoma